Form:Supplied as a liquid in 0.7% BSA, 0.09% sodium azide.
Specificity:Recognizes human leukocyte antigen-DR (HLA-DR). Has lymph node germinal center and mantle zone B cell reactivity. Reacts with interdigitating histiocytes in T cell zones and with sinus histiocytes and endothelial cells. Also tumor specificity and reactivity with normal non-lymphoid tissue.